LQDA.NASDAQLiquidia CORP

Form 4: Liquidia Corp Chief HR Officer Granted 25,000 Restricted Stock Units

Sentiment:

Insider Transaction Report


Liquidia Corp's Chief Human Resource Officer, Sarah Krepp, was granted 25,000 restricted stock units (RSUs) on July 1, 2025, as part of her compensation.

Summary

  • Sarah Krepp, Chief Human Resource Officer of Liquidia Corp (LQDA), acquired 25,000 shares of common stock in the form of Restricted Stock Units (RSUs) on July 1, 2025.
  • The acquisition price for these RSUs was $0, indicating a grant rather than a purchase.
  • Following this transaction, Sarah Krepp beneficially owns a total of 145,172 shares of Liquidia Corp common stock.
  • The newly granted 25,000 RSUs will vest with 25% on July 11, 2026, and the remaining portion vesting ratably on a quarterly basis over three years thereafter.
  • The total beneficial ownership of 145,172 shares includes 40,381 unvested RSUs from a January 11, 2024 grant, 12,459 RSUs from a July 1, 2024 grant, 50,861 RSUs from a January 11, 2025 grant, and 4,472 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan, in addition to the current 25,000 RSU grant.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it reflects a standard executive compensation practice that aligns management's interests with shareholders, indicating stability and long-term incentive for a key officer.

Positives

  • The grant of Restricted Stock Units to a key officer aligns management's long-term interests with those of shareholders, promoting retention and performance.
  • RSU grants are a common form of equity compensation, indicating standard corporate practices for executive incentives.

Future Outlook

The future outlook for the granted RSUs involves a structured vesting schedule, with the first 25% vesting on July 11, 2026, and the remainder vesting quarterly over the subsequent three years, indicating a long-term incentive structure.

Industry Context

The grant of Restricted Stock Units to a Chief Human Resource Officer is a standard practice in the biotechnology and pharmaceutical industries for executive compensation, aiming to attract, retain, and incentivize key talent by aligning their financial interests with the company's long-term performance and shareholder value.

Comparison to Industry Standards

  • RSU grants are a prevalent form of equity compensation across various industries, including biotech, for executive and key employee retention and motivation.
  • The vesting schedule, typically over several years, is consistent with industry norms designed to encourage long-term commitment and performance.
  • While specific comparable companies or projects are not detailed in this filing, the structure of this RSU grant aligns with general compensation strategies observed in publicly traded companies of similar size and sector.

Related Party Transactions

  • The grant of 25,000 Restricted Stock Units to Sarah Krepp, an officer of Liquidia Corp, constitutes a related party transaction as it involves compensation provided by the company to a key management personnel.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the interests of the Chief Human Resource Officer with shareholders, potentially leading to better long-term performance and value creation.
  • Employees: This grant is part of the company's compensation strategy, which can influence employee morale and retention, particularly for key personnel.

Next Steps

  • The vesting of the 25,000 RSUs will commence with 25% on July 11, 2026.
  • Remaining RSUs will vest ratably on a quarterly basis over three years following the initial vesting date.

Key Dates

DateDescription
01/11/2024Date of a previous RSU grant of 61,465 RSUs to the Reporting Person, of which 40,381 remain unvested.
07/01/2024Date of a previous RSU grant of 12,459 RSUs to the Reporting Person, none of which had vested as of July 1, 2025.
01/11/2025Date of a previous RSU grant of 50,861 RSUs to the Reporting Person, none of which had vested as of July 1, 2025.
07/01/2025Date of the reported transaction, where 25,000 RSUs were granted to Sarah Krepp.
07/03/2025Signature date of the Form 4 filing.
07/11/2026First vesting date for 25% of the 25,000 RSUs granted on July 1, 2025.

Keywords

Liquidia Corp, LQDA, Sarah Krepp, Restricted Stock Units, RSU, Insider Transaction, Form 4, Equity Compensation, Beneficial Ownership, Chief Human Resource Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.